Cai, L., Zhao, Y., Li, Z., Xiao, L., Wu, Y., Wang, S., . . . Zhang, D. A Human Engineered Heart Tissue‐Derived Lipotoxic Diabetic Cardiomyopathy Model Revealed Early Benefits of Empagliflozin. Wiley.
Chicago Style (17th ed.) CitationCai, Lin, et al. A Human Engineered Heart Tissue‐Derived Lipotoxic Diabetic Cardiomyopathy Model Revealed Early Benefits of Empagliflozin. Wiley.
MLA (9th ed.) CitationCai, Lin, et al. A Human Engineered Heart Tissue‐Derived Lipotoxic Diabetic Cardiomyopathy Model Revealed Early Benefits of Empagliflozin. Wiley.
Warning: These citations may not always be 100% accurate.